Redefining the Adjuvant Landscape and Radiation Sequencing in Merkel Cell Carcinoma
New evidence supports sequential pembrolizumab after radiotherapy for high-risk Merkel cell carcinoma, reducing disease recurrence, preventing distant metastases, and reshaping multidisciplinary postoperative treatment strategies.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.